Showing results (171-180 of 574) with videos related to
Sort By:
Pageof 58
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infectionG P Bodey, E Anaissie, J Gutterman, et al.The American Journal of Medicine|January 1, 1979
Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remissionG P Bodey, V Rodriguez, F Cabanillas, et al.Medicine|March 1, 1979
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignanciesM J Keating, G P Bodey, M Valdivieso, et al.Cancer Treatment Reports|September 1, 1981
Broad phase II study of vindesineM Valdivieso, A Y Bedikian, G P Bodey, et al.Antimicrobial Agents and Chemotherapy|December 1, 1984
Effect of aztreonam on throat and stool flora of cancer patientsP G Jones, G P Bodey, E A Swabb, et al.Reviews of Infectious Diseases|November 1, 1990
Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancerN Khardori, L Elting, E Wong, et al.Reviews of Infectious Diseases|March 1, 1990
Prophylaxis of oropharyngeal candidiasis with fluconazoleG Samonis, K Rolston, C Karl, et al.Antimicrobial Agents and Chemotherapy|August 1, 1990
In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agentsN Khardori, A Reuben, B Rosenbaum, et al.Cancer Treatment Reports|January 1, 1983
Phase I evaluation of oral tegafurA Y Bedikian, G P Bodey, M Valdivieso, et al.The American Journal of Medicine|March 1, 1983
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic typeF Cabanillas, M A Burgess, G P Bodey, et al.Pageof 58